Protection against concanavalin A-induced hepatocyte apoptosis by molsidomine is time-dependent

Journal of the American College of Surgeons

Volumn 198, Issue 1, 2004, Pages 67-77

  Ding, Jin Wen ^a,b   Wang, Kewei ^a   Brems, John J ^a   Gamelli, Richard L ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CASPASE 3; CASPASE 8; CONCANAVALIN A; DNA FRAGMENT; INDUCIBLE NITRIC OXIDE SYNTHASE; MOLSIDOMINE; N6 (1 IMINOETHYL)LYSINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; TIME; WESTERN BLOTTING;

EID: 1042287415     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2003.08.014     Document Type: Article

References (34)

1. Ando K., Moriyama T., Guidotti L.G., et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J Exp Med. 178:1993;1541-1554.
2. Diepolder H.M., Zachoval R., Hoffmann R.M., et al. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection. Lancet. 346:1995;1006-1007.
3. Heneghan M.A., McFarlane I.G. Current and novel immunosuppressive therapy for autoimmune hepatitis. [review] Hepatology. 35:2002;7-13.
4. Kita H., Mackay I.R., Van De Water J., Gershwin M.E. The lymphoid liver considerations on pathways to autoimmune injury . [review] Gastroenterology. 120:2001;1485-1501.
5. Gantner F., Leist M., Lohse A.W., et al. Concanavalin A-induced T-cell-mediated hepatic injury in mice the role of tumor necrosis factor . Hepatology. 21:1995;190-198.
6. Kusters S., Gantner F., Kunstle G., Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology. 111:1996;462-471.
7. Seino K., Kayagaki N., Takeda K., et al. Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology. 113:1997;1315-1322.
8. Yin X.M. Bid, a critical mediator for apoptosis induced by the activation of Fas/TNF-R1 death receptors in hepatocytes. J Mol Med. 78:2000;203-211.
9. Li P., Nijhawan D., Budihardjo I., et al. Cytochrome c and dATP-dependent formation of apoptosis activating factor-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 91:1997;479-489.
10. Zheng LA, Li JH, Kluger MS, et al. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Am J Pathol 2002;161:1485-1495.
11. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
12. Hierholzer C., Harbrecht B., Menezes J.M., et al. Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med. 187:1998;917-928.
13. Menezes J., Hierholzer C., Watkins S.C., et al. A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock. Am J Physiol. 277:1999;G144-G151.
14. Isobe M., Katsuramaki T., Hirata K., et al. Beneficial effects of inducible nitric oxide synthase inhibitor on reperfusion injury in the pig liver. Transplantation. 68:1999;803-813.
15. Thiemermann C., Ruetten H., Wu C.C., Vane J.R. The multiple organ dysfunction syndrome caused by endotoxin in the rat attenuation of liver dysfunction by inhibitors of nitric oxide synthase . Br J Pharmacol. 116:1995;2845-2851.
16. Sass G., Koerber K., Bang R., et al. Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J Clin Invest. 107:2001;439-447.
17. Morikawa A., Kato Y., Sugiyama T., et al. Role of nitric oxide in lipopolysaccharide-induced hepatic injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model. Infect Immun. 67:1999;1018-1024.
18. Bohlinger I., Leist M., Barsig J., et al. Interleukin-1 and nitric oxide protect against tumor necrosis factor alpha-induced liver injury through distinct pathways. Hepatology. 22:1995;1829-1837.
19. Fiorucci S., Santucci L., Antonelli E., et al. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology. 18:2000;404-421.
20. Ou J., Carlos T.M., Watkins S.C., et al. Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. Nitric Oxide. 1:1997;404-416.
21. Saavedra J.E., Billiar T.R., Williams D.L., et al. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-alpha-induced apoptosis and toxicity in the liver. J Med Chem. 40:1997;1947-1954.
22. Mojena M., Hortelano S., Castrillo A., et al. Protection by nitric oxide against liver inflammatory injury in animals carrying a nitric oxide synthase-2 transgene. FASEB J. 15:2001;583-585.
23. Kim Y.M., Kim T.H., Chung H.T., et al. Nitric oxide prevents tumor necrosis factor alpha-induced rat hepatocyte apoptosis by the interruption of mitochondrial apoptotic signaling through S-nitrosylation of caspase-8. Hepatology. 32:2000;770-778.
24. Li J., Billiar T.R., Talanian R.V., Kim Y.M. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem Biophys Res Commun. 240:1997;419-424.
25. Mannick J.B., Hausladen A., Liu L., et al. Fas-induced caspase denitrosylation. Science. 284:1999;651-654.
26. Torok N.J., Higuchi H., Bronk S., Gores G.J. Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitrosylating caspase 9. Cancer Res. 62:2002;1648-1653.
27. Rossig L., Fichtlscherer B., Breitschopf K., et al. Nitric oxide inhibits caspase-3 by S-nitrosylation in vivo. J Biol Chem. 274:1999;6823-6826.
28. Kim P.K., Billiar T.R. Give me iNOS or give me death. Hepatology. 34:2001;436-437.
29. Melino G., Bernassola F., Knight R.A., et al. S-nitrosylation regulates apoptosis. Nature. 388:1997;432-433.
30. Bursch W., Paffe S., Putz B., et al. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis. 11:1990;847-853.
31. Rosenkranz B., Winkelmann B.R., Parnham M.J. Clinical pharmacokinetics of molsidomine. Clin Pharmacokinet. 30:1996;372-384.
32. Kumins N.H., Hunt J., Gamelli R.L., Filkins J.P. Molsidomine increases endotoxic survival and decreases cytokine production. Shock. 7:1997;200-205.
33. Moazzam F.N., Brems J.J., Yong S.L., et al. Endotoxin potentiates hepatocyte apoptosis in cholestasis. J Am Coll Surg. 194:2002;731-739.
34. Mizuhara H., Kuno M., Seki N., et al. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice. Hepatology. 27:1998;513-519.